Ampere hepatitis C virus antibody Western ink dot method third-generation test reagent set
Taiwan·Risk Class 3·MP BIOMEDICALS ASIA PACIFIC PTE. LTD.·Registered Mar 23, 2015 – Mar 23, 2030Active- Analysis ID
- a9e4d07d9efe0eb3b94ef7186e4b2b5e
- Customs Code
- DHA05602718308
- Manufacturer
- MP BIOMEDICALS ASIA PACIFIC PTE. LTD.
- Manufacturer Country
- Singapore
- Authorized Representative
- ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.)
- Intended Use
- This product uses enzyme immunoassay to qualitatively detect hepatitis C virus antibodies in human serum and plasma. This product is not approved for blood donor screening.
- Product Type (Level 1)
- B Hematology, pathology, and genetics
- Product Type (Level 2)
- B.4020 Analysis of specific tests
- Import Information
- import
- Registration Date
- Mar 23, 2015
- Expiry Date
- Mar 23, 2030
Access comprehensive regulatory information for Ampere hepatitis C virus antibody Western ink dot method third-generation test reagent set in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number a9e4d07d9efe0eb3b94ef7186e4b2b5e and manufactured by MP BIOMEDICALS ASIA PACIFIC PTE. LTD.. The authorized representative in Taiwan is ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.